Avalo Therapeutics, Inc. (AVTX)
14.21
-1.76
(-11.02%)
USD |
NASDAQ |
Feb 20, 16:00
14.17
-0.04
(-0.28%)
After-Hours: 20:00
Avalo Therapeutics EPS Diluted (TTM) : -8.730 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| AbbVie, Inc. | 2.361 |
| ACADIA Pharmaceuticals, Inc. | 1.554 |
| Alnylam Pharmaceuticals, Inc. | 2.257 |
| Savara, Inc. | -0.5351 |
| BioMarin Pharmaceutical, Inc. | 2.669 |